NEWS
- Ultimate Insight into PEG Linkers and Its Application
- What Are ADC Linkers: Cleavable vs. Non-Cleavable Linkers
- Topoisomerase I inhibitors Based ADCs: SN-38 & DXd
- FDA Approved Complement Inhibitors: C3, C5 & Factor B/D Targeted Therapies
- The Bystander Effect of ADCs
- FDA Approved Antibody-Drug Conjugates (ADCs) By 2026
- Current & Emerging Geographic Atrophy Therapies
- Molecular Glue Degraders in Clinical Trails: 2026 Update
- First Bispecific ADC Approved Globally: More Bispecific ADCs in Clinical Trials
- Nucleic Acid Therapeutics: Approvals and Potential Blockbusters
